We don’t just slow bone loss. The London Osteoporosis Clinic uses consultant-led assessments, targeted nutrition, and clinical monitoring to actively rebuild your skeletal strength.
Whether you are concerned about your own bone health, referring a patient, or considering bone health within an organisational risk framework — there is a defined entry point.
Most osteoporosis care in the United Kingdom is anti-resorptive — it slows the rate at which bone is lost. That is necessary, and often appropriate. It is rarely sufficient.
LOC’s clinical philosophy goes further. Where the clinical picture allows, the objective is to actively rebuild bone — to increase bone mineral density forward, year on year, measurable on DXA. The BoneRevive® programme typically achieves 8–12% BMD improvement per year. Over a five-year horizon, that is a fundamentally different fracture trajectory.
This requires a complete clinical picture: density, microarchitecture, turnover markers, nutritional status, hormonal context, medication review, and personal risk profile. It requires structured monitoring, not single-visit care. And it requires consultant-level judgement about when to use medication, which agent, for what duration — and when not to.
Each stage produces a deliverable — a quantified risk picture, a personalised plan, a measurable change. Patients are not handed a prescription and discharged; they are placed within a pathway that is monitored over time.
Detailed clinical history, physical examination, and consultation with Dr Mahmud or a senior member of the team. Identification of risk factors, secondary causes, and reversible contributors. Output: a structured clinical formulation.
DXA scan, vertebral fracture assessment, trabecular bone score where indicated, bone turnover markers, and a focused metabolic panel. FRAX or QFracture risk synthesis. Output: a quantified picture of bone status and 10-year fracture risk.
A bespoke plan combining nutrition, loading exercise, lifestyle modification, secondary-cause management, and — where appropriate — anabolic or anti-resorptive pharmacological treatment. Output: an active programme with defined milestones.
Repeat DXA, ongoing turnover marker review, treatment adjustment, and longitudinal capability tracking. Bone health is not a single intervention; it is a sustained programme. Output: measurable forward change, year on year.
Dr Taher Mahmud is a Consultant Rheumatologist who has built his career around a single clinical conviction: that osteoporosis is not an inevitable consequence of ageing, but a measurable, modifiable, and frequently reversible condition.
His clinical work, his patents, and the LOC programme are built on this position. The methods are not speculative — they are anchored in measurable bone density gain and longitudinal outcomes data, delivered through a structured pathway and monitored on DXA over time.
As a Trustee of the Global Osteoporosis Foundation, he leads the Fracture-Free Future 2040™ initiative — a long-term effort to eliminate preventable fragility fractures globally.
A consultant-led bone health assessment quantifies your position, identifies modifiable factors, and defines the pathway forward — with measurable outcomes tracked year on year.
GET LATEST UPDATES
© London Osteoporosis Clinic™ — Consultant-led assessment & treatment
